Investigational Drug Information for Methylthioninium
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
What is the drug development status for Methylthioninium?
Methylthioninium is an investigational drug.
There have been 8 clinical trials for Methylthioninium.
The most recent clinical trial was a Phase 3 trial, which was initiated on March 31st 2018.
The most common disease conditions in clinical trials are Carcinoma, Squamous Cell, Dementia, and Mucositis. The leading clinical trial sponsors are Fundação Educacional Serra dos Órgãos, M.D. Anderson Cancer Center, and Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS).
There are thirty-three US patents protecting this investigational drug and three international patents.
Summary for Methylthioninium
| US Patents | 33 |
| International Patents | 3,082 |
| US Patent Applications | 2,821 |
| WIPO Patent Applications | 216 |
| Japanese Patent Applications | 3,037 |
| Clinical Trial Progress | Phase 3 (2018-03-31) |
| Vendors | 17 |
Recent Clinical Trials for Methylthioninium
| Title | Sponsor | Phase |
|---|---|---|
| COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy | Prokhorov General Physics Institute of the Russian Academy of Sciences (GPI RAS) | Phase 1 |
| COVID-19 Treatment Using Methylene Blue and Photodynamic Therapy | I.M. Sechenov First Moscow State Medical University | Phase 1 |
| MOM's PAIN (Methylene Blue for Oral Mucositis' PAIN) | M.D. Anderson Cancer Center | Phase 2 |
Clinical Trial Summary for Methylthioninium
Top disease conditions for Methylthioninium
Top clinical trial sponsors for Methylthioninium
US Patents for Methylthioninium
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Methylthioninium | See Plans and Pricing | Multimodal silica-based nanoparticles | See Plans and Pricing | |
| Methylthioninium | See Plans and Pricing | Up and down conversion systems for production of emitted light from various energy sources including radio frequency, microwave energy and magnetic induction sources for upconversion | IMMUNOLIGHT, LLC (Detroit, MI) DUKE UNIVERSITY (Durham, NC) | See Plans and Pricing |
| Methylthioninium | See Plans and Pricing | Compostions and methods for diagnosis of axial pain with or without radiculopathy | Warsaw Orthopedic, Inc. (Warsaw, IN) | See Plans and Pricing |
| Methylthioninium | See Plans and Pricing | Screening method | Iomet Pharma Ltd. (Midlothian, GB) | See Plans and Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Methylthioninium
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Methylthioninium | Australia | AU2013240312 | 2032-03-30 | See Plans and Pricing |
| Methylthioninium | Australia | AU2013326904 | 2032-03-30 | See Plans and Pricing |
| Methylthioninium | Australia | AU2014238036 | 2032-03-30 | See Plans and Pricing |
| Methylthioninium | Australia | AU2018241060 | 2032-03-30 | See Plans and Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
